3- Severe peripheral vascular disease. 4- Malignancy within the last two to five years other than non-melanoma skin cancers. Candidates with a previous malignancy will be evaluated individually based on surgery notes, pathology reports, and cancer treatment records. 5- Moderately severe or severe cardiac disease, including ischemic myocardial disease, congestive heart failure, valvular disease and myopathies. 6- Chronic active inflammatory or infectious diseases. 7- Obesity or malnutrition to the extent that this factor significantly impacts surgical risk and life expectancy. 8- Chronic upper respiratory disease. 9- Uncorrected lower urinary tract abnormalities. 10. Inability to provide adequate psychosocial support plan. 11. Inability to provide adequate financial plan for provision of medications and the costs associated with post-transplant care. 12. Failure to follow no show/cancellation policy. 13. Failure to complete required testing and/or transplant plan within program timeframe guidelines. 14. Non-adherence with dialysis and medical treatment regimen. 15. Failure to maintain contact with the transplant center. Timeframe for re-evaluation: see the Waitlist management policy Alternative Therapy for Transplantation Potential therapies may include but are not limited to: hemodialysis and peritoneal dialysis. If you are diabetic you may benefit from insulin pump therapy. RELATED DOCUMENT(S)/LINK(S): DEFINITIONS: (If applicable) BMI Body Mass Index – SPK-Simultaneous Pancreas/Kidney Transplant PAK-Pancreas After Kidney Transplant PTA-Pancreas Transplant Alone IV-Intravenous REFERENCES AND SOURCES OF EVIDENCE: 1. Kasiske, B.L. and D. Klinger, Cigarette smoking in renal transplant recipients. J Am Soc Nephrol, 2000. 11(4): p. 753-9. 2. Biesenbach, G., et al., Impact of smoking on progression of vascular diseases and patient survival in type-1 diabetic patients after simultaneous kidney-pancreas transplantation in a single centre. Transpl Int, 2008. 21(4): p. 357-63.
3- Severe peripheral vascular disease. 4- Malignancy within the last two to five years other than non-melanoma skin cancers. Candidates with a previous malignancy will be evaluated individually based on surgery notes, pathology reports, and cancer treatment records. 5- Moderately severe or severe cardiac disease, including ischemic myocardial disease, congestive heart failure, valvular disease and myopathies. 6- Chronic active inflammatory or infectious diseases. 7- Obesity or malnutrition to the extent that this factor significantly impacts surgical risk and life expectancy. 8- Chronic upper respiratory disease. 9- Uncorrected lower urinary tract abnormalities. 10. Inability to provide adequate psychosocial support plan. 11. Inability to provide adequate financial plan for provision of medications and the costs associated with post-transplant care. 12. Failure to follow no show/cancellation policy. 13. Failure to complete required testing and/or transplant plan within program timeframe guidelines. 14. Non-adherence with dialysis and medical treatment regimen. 15. Failure to maintain contact with the transplant center. Timeframe for re-evaluation: see the Waitlist management policy Alternative Therapy for Transplantation Potential therapies may include but are not limited to: hemodialysis and peritoneal dialysis. If you are diabetic you may benefit from insulin pump therapy. RELATED DOCUMENT(S)/LINK(S): DEFINITIONS: (If applicable) BMI – Body Mass Index SPK-Simultaneous Pancreas/Kidney Transplant PAK-Pancreas After Kidney Transplant PTA-Pancreas Transplant Alone IV-Intravenous REFERENCES AND SOURCES OF EVIDENCE: 1. Kasiske, B.L. and D. Klinger, Cigarette smoking in renal transplant recipients. J Am Soc Nephrol, 2000. 11(4): p. 753-9. 2. Biesenbach, G., et al., Impact of smoking on progression of vascular diseases and patient survival in type-1 diabetic patients after simultaneous kidney-pancreas transplantation in a single centre. Transpl Int, 2008. 21(4): p. 357-63.